# Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy

> **NCT05570409** · PHASE2,PHASE3 · TERMINATED · sponsor: **LMU Klinikum** · enrollment: 9 (actual)

## Conditions studied

- Inflammatory Cardiomyopathy

## Interventions

- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Prednisolone
- **DRUG:** Mycophenolate Mofetil Placebo
- **DRUG:** Prednisolone Placebo

## Key facts

- **NCT ID:** NCT05570409
- **Lead sponsor:** LMU Klinikum
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-28
- **Primary completion:** 2025-04-14
- **Final completion:** 2025-04-14
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Premature end of recruitment due to lack of eligible patients. Within two years of recruitment only nine patients could be randomized out of 130 required patients as per trial protocol.
- **Last updated:** 2025-07-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05570409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05570409, "Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05570409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*